PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, marking an earnings surprise of -2.17%. Despite the loss, the company surpassed revenue expectations, posting $94.5 million against an estimated $92.5 …